164 related articles for article (PubMed ID: 32234294)
1. Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications.
Papoutselis M; Spanoudakis E
Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):358-365. PubMed ID: 32234294
[TBL] [Abstract][Full Text] [Related]
2. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
3. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
4. Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation.
Veerapen N; Kharkwal SS; Jervis P; Bhowruth V; Besra AK; North SJ; Haslam SM; Dell A; Hobrath J; Quaid PJ; Moynihan PJ; Cox LR; Kharkwal H; Zauderer M; Besra GS; Porcelli SA
Bioconjug Chem; 2018 Sep; 29(9):3161-3173. PubMed ID: 30085659
[TBL] [Abstract][Full Text] [Related]
5. Innate-like recognition of microbes by invariant natural killer T cells.
Kronenberg M; Kinjo Y
Curr Opin Immunol; 2009 Aug; 21(4):391-6. PubMed ID: 19646850
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting.
Rotolo A; Caputo VS; Holubova M; Baxan N; Dubois O; Chaudhry MS; Xiao X; Goudevenou K; Pitcher DS; Petevi K; Kachramanoglou C; Iles S; Naresh K; Maher J; Karadimitris A
Cancer Cell; 2018 Oct; 34(4):596-610.e11. PubMed ID: 30300581
[TBL] [Abstract][Full Text] [Related]
7. Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).
Fichtner AS; Paletta D; Starick L; Schumann RF; Niewiesk S; Herrmann T
Immunology; 2015 Dec; 146(4):618-29. PubMed ID: 26346465
[TBL] [Abstract][Full Text] [Related]
8. The ins and outs of type I iNKT cell development.
Shissler SC; Webb TJ
Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
[TBL] [Abstract][Full Text] [Related]
9. Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.
Dhodapkar MV; Richter J
Clin Immunol; 2011 Aug; 140(2):160-6. PubMed ID: 21233022
[TBL] [Abstract][Full Text] [Related]
10. Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.
Kronenberg M
J Vis Exp; 2007; (10):635. PubMed ID: 18989407
[TBL] [Abstract][Full Text] [Related]
11. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
Venkataswamy MM; Porcelli SA
Semin Immunol; 2010 Apr; 22(2):68-78. PubMed ID: 19945296
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features.
Lameris R; de Bruin RC; van Bergen En Henegouwen PM; Verheul HM; Zweegman S; de Gruijl TD; van der Vliet HJ
Immunology; 2016 Sep; 149(1):111-21. PubMed ID: 27312006
[TBL] [Abstract][Full Text] [Related]
13. The role of invariant NKT cells at the interface of innate and adaptive immunity.
Cerundolo V; Kronenberg M
Semin Immunol; 2010 Apr; 22(2):59-60. PubMed ID: 20172739
[No Abstract] [Full Text] [Related]
14. iNKT cells in microbial immunity: recognition of microbial glycolipids.
Kinjo Y; Ueno K
Microbiol Immunol; 2011 Jul; 55(7):472-82. PubMed ID: 21434991
[TBL] [Abstract][Full Text] [Related]
15. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D
J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038
[TBL] [Abstract][Full Text] [Related]
16. The glycolipid exoantigen derived from Chlamydia muridarum activates invariant natural killer T cells.
Peng Y; Zhao L; Shekhar S; Liu L; Wang H; Chen Q; Gao X; Yang X; Zhao W
Cell Mol Immunol; 2012 Jul; 9(4):361-6. PubMed ID: 22728762
[TBL] [Abstract][Full Text] [Related]
17. [Recognition of CD1d/glycolipid antigen complex by NKT cells and mechanisms in immune regulation].
Watarai H; Tashiro T; Chiba T; Taniguchi M
Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1584-9. PubMed ID: 21089371
[No Abstract] [Full Text] [Related]
18. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
Yang G; Artiaga BL; Lewis ST; Driver JP
Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
[TBL] [Abstract][Full Text] [Related]
19. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.
Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
Haematologica; 2013 Mar; 98(3):376-84. PubMed ID: 23065503
[TBL] [Abstract][Full Text] [Related]
20. Immunometabolic Activation of Invariant Natural Killer T Cells.
Ververs FA; Kalkhoven E; Van't Land B; Boes M; Schipper HS
Front Immunol; 2018; 9():1192. PubMed ID: 29892305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]